Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Sharansky donates his $1 million Genesis Prize to alleviate coronavirus suffering, protect against future pandemics


News provided by

The Genesis Prize Foundation

04 May, 2020, 03:00 GMT

Share this article

Share toX

Share this article

Share toX

Genesis, in partnership with Start-Up Nation Central, to award additional prizes to Israeli companies working to defeat COVID-19

JERUSALEM, May 4, 2020 /PRNewswire/ -- The Genesis Prize Foundation (GPF) announced today the names of the 15 recipients of this year's Genesis Prize grants. The majority of the funding for the grants came from the $1 million Genesis Prize, which was awarded to the legendary human rights activist Natan Sharansky last December. Sharansky chose to direct these funds to organizations fighting the coronavirus pandemic and supporting individuals most affected by it. 

Continue Reading
This image opens in the lightbox
2020 Genesis Prize Laureate Natan Sharansky. Photo Credit: Oren Fixler Flash90

"The selection of Natan Sharansky as the 2020 Genesis Prize Laureate coincided with the beginning of the worst pandemic faced by humanity in the past one hundred years," said Stan Polovets, Co-Founder and Chairman of The Genesis Prize Foundation. "Natan felt strongly that the most positive impact he could have as the Genesis Prize Laureate is to donate his $1 million prize in its entirety to organizations combating coronavirus and helping individuals most impacted by this vicious, invisible enemy."

"Many people of good will around the world have given generously to help organizations and individuals who have been devastated by COVID-19; I am grateful to have the opportunity to contribute to this humanitarian effort," said Natan Sharansky. "Throughout the long history of the Jewish people, our ability to come together as one during the times of crisis - to unite and help each other - gave us strength to persevere and face the future with hope and confidence. That's why I cannot think of a better way to use the Genesis Prize money than to fund those who are fighting the coronavirus epidemic, both in Israel and around the world."

Genesis Co-Founder Polovets noted that some of the grants will deliver immediate relief to those most affected; others will seed longer-term advances against the disease. The former group includes Israeli organization 1221 Assistance for All – an emergency support service for residents of Jerusalem; ALEH Negev, working with children with severe disabilities; Association of Rape Crisis Centers of Israel, responding to a 40% increase in domestic violence cases; Hillel and Moishe House, supporting isolated elderly in Europe and the Former Soviet Union.

Among the projects with a longer-term focus are grants to Israel's Weizmann Institute's research program to develop a coronavirus vaccine, and two leading US universities, Columbia and New York University (NYU). The grant to Columbia University Irving Medical Center provides seed funds for researchers to develop new treatments, while the grant to NYU's Tandon School of Engineering funds a competition for undergraduate and graduate students to address the acute engineering challenges presented by the coronavirus, including creating "zero contact" hardware, such as doors and payment systems.

"New York has suffered the highest number of COVID-19 cases in the world; the city – and its Jewish community – have been profoundly affected. The grants to Columbia and NYU provide additional resources to the two world-class centers of scientific excellence in New York – where The Genesis Prize Foundation is headquartered – as they work to help the city emerge from the current crisis," said GPF's Polovets.

Morris Kahn, a prominent Israeli philanthropist who contributed additional funds in honor of Natan Sharansky, said: "We are not only battling to save the lives of those infected by COVID-19; the harsh reality has threatened the lives of many, including victims of domestic violence and those less fortunate in need of medical attention. Mr. Sharansky is an example of a true believer in life and the bounty of life, his decision to support these important organizations is the core of the Jewish values – to be compassionate and help ease the pain of others."

Isaac Herzog, Chairman of the Jewish Agency for Israel and Chairman of the Genesis Prize Selection Committee, said: "I admire Natan's decision to donate his award in this hour of profound need. The range of projects selected for Genesis Prize grants is strategic, comprehensive and addresses the need for immediate humanitarian relief as well as preparedness for the challenges of tomorrow. The Jewish Agency is honored to partner with Natan and the Genesis Prize in this 2020 philanthropic program."    

In addition to the fifteen grants, Genesis announced a special competition in honor of Sharansky, which will recognize Israeli companies working to combat COVID-19 and mitigate the damage from future pandemics. Start-Up Nation Central, an NGO founded by philanthropist Paul Singer, will run the competition in partnership with GPF to promote Israeli innovation globally. GPF and Start-Up Nation Central will award prizes to selected Israeli companies, which either have made significant contributions to the effort to fight COVID-19 or are working on promising technologies, therapies, or vaccines that have the potential to provide significant benefits in the near future. Winners of the competition, to be held in the summer, will donate their prize funds to the charities of their choice. 

For additional information about the grantees: https://www.genesisprize.org/laureate-initiatives/fighting-the-coronavirus-pandemic

BACKGROUND

The annual Genesis Prize, dubbed the "Jewish Nobel" by TIME Magazine, honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, and commitment to Jewish values. Legendary Jewish leader and activist Natan Sharansky was announced in December 2019 as the 8th Genesis Prize Honoree in recognition of his life-long advocacy for human rights, democracy, service to the Jewish people and the State of Israel.

Launched in 2013, the Prize is financed through a permanent endowment of $100 million established by The Genesis Prize Foundation.

Previous Genesis Prize laureates are former New York City Mayor Michael Bloomberg; actor, producer and peace activist Michael Douglas; virtuoso violinist and advocate for individuals with special needs Itzhak Perlman; sculptor and advocate for the rights of refugees Sir Anish Kapoor; Oscar-winning actress and social activist Natalie Portman; and owner of New England Patriots and founder of the leading foundation to combat anti-Semitism Robert Kraft. In 2018, the Genesis Prize Foundation honored U.S. Supreme Court Justice Ruth Bader Ginsburg with its inaugural Lifetime Achievement Award for her contribution to social justice and equal rights.

All laureates have selected causes that are important to them, and award funds in their honor have been donated to these causes. These initiatives have included support of social entrepreneurship based on Jewish values, inclusiveness of intermarried families in Jewish life, improving the lives of individuals with special needs, helping to alleviate the global refugee crisis, advancing women's equality, and combatting anti-Semitism and efforts to delegitimize the State of Israel.

Photo - https://mma.prnewswire.com/media/1163318/Genesis_Prize_Natan_Sharansky.jpg

Related Links

http://www.genesisprize.org

Modal title

Also from this source

Argentina's President Javier Milei Wins the 2025 "Jewish Nobel Prize"

Today, The Genesis Prize announces President of Argentina Javier Milei as the 2025 Genesis Prize Laureate, the first time the award, known as "The...

More Releases From This Source

Explore

Infection Control

Infection Control

Health Care & Hospitals

Health Care & Hospitals

Not For Profit

Not For Profit

Religion

Religion

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.